Received by email:
File: Attachment NR- CFO Appointment- 05-08-22.pdf
NIRVANA APPOINTS NEW CHIEF FINANCIAL OFFICER
VANCOUVER, B.C. August 5, 2022 (NEWSFILE) - Nirvana Life Sciences Inc., (CSE:NIRV) ("Nirvana" or the
"Company") a Canadian based life sciences company aimed at developing non-addictive chronic pain
and addiction treatment products announces that Connie Hang has resigned as Chief Financial Officer
of the Company. The Company thanks Ms. Hang for her work as CFO over the last 2 years, she will
continue serving the Company as a Contractor.
Annie Storey, CPA, CA, BBA has been appointed as Chief Financial Officer, effective immediately. Ms.
Storey, a director of the Company since 2017, brings over 25 years' experience in accounting, auditing,
financial reporting and corporate services for Canadian and US public companies in the mining,
entertainment and biotechnology sectors.
Ms Storey has a keen interest in the development new approaches to manage addictions and currently
serves as a director of the advocacy group Moms Stop the Harm.
About Nirvana Life Sciences
Nirvana Life Sciences Inc. (CSE:NIRV) is an innovator in the emerging Psychedelic space. Its business
model combines the development of novel formulations for drug development with the development
of laboratory space to support ongoing development and manufacturing. At Nirvana, we believe that
psylocibin derived medicines can play a leading role in reducing the impacts of the opioids crisis and
build healthier communities. For more information visit https://nirvanalifescience.com/
For further information:
Bruce Clark CEOinfo@nirvanalifescience.com
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and
accepts no responsibility for the adequacy or accuracy hereof.
This news release contains certain forward-looking statements and forward-looking information (collectively
referred to herein as "forward-looking statements") within the meaning of Canadian securities laws including,
without limitation, statements with respect to the future investments by the Company. All statements other than
statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-
looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to
known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the
future events or circumstances contemplated by the forward-looking statements will not occur. Although the
Company believes that the expectations reflected in the forward-looking statements contained in this press
release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be
no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance
on forward-looking statements included in this document, as there can be no assurance that the plans, intentions
or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking
statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the
possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which
may cause the Company's actual performance and results in future periods to differ materially from any estimates
or projections of future performance or results expressed or implied by such forward-looking statements. The
forward-looking statements contained in this news release are made as of the date hereof and the Company
does not undertake any obligation to update publicly or to revise any of the included forward-looking
statements, except as required by applicable law. The forward-looking statements contained herein are expressly
qualified by this cautionary statement
NIRVANA LIFE SCIENCES INC.
© 2022 Canjex Publishing Ltd. All rights reserved.